Induction of hepatic CYP2B in foetal and neonatal rats after maternal administration of phenobarbital

Pharmacology and Toxicology

Volumn 84, Issue 1, 1999, Pages 18-23

  Asoh, Masako ^a   Tateishi, Tomonori ^a   Kumai, Toshio ^a   Kobayashi, Shinichi ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2B; CYTOCHROME P450 ISOENZYME; PHENOBARBITAL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INDUCTION; EPILEPSY; FETUS LIVER; INTRAUTERINE GROWTH RETARDATION; NONHUMAN; PLACENTAL TRANSFER; PRENATAL EXPOSURE; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0032931663     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1999.tb02105.x     Document Type: Article

References (26)

1. Agrawal, A. K. & B. H. Shapiro: Imprinted overinduction of hepatic CYP2B1 and 2B2 in adult rats neonatally exposed to phenobarbital. J. Pharmacol. Exp. Therap. 1996, 279, 991-999.
2. Burger, H. J., E. G. Schuetz & J. D. Schuetz: Divergent effects of cycloheximide on induction of class II and class III cytochrome P450 mRNAs in cultures of adult rat hepatocytes. Arch. Biochem. Biophys. 1990, 281, 204-211.
3. Chadwick, D: Standard approach to antiepileptic drug treatment in the united kingdom. Epilepsia 1994, 35 (Suppl.4), S3-S10.
4. Cramer, J. A. & R. H. Mattson: Phenobarbital toxicity. In: Antiepileptic drugs, 4th ed. Eds.: R. H. Levy, R. H. Mattoson & B. S. Meldrum. Raven Press, New york, New York, USA, 1995, pp. 409-420.
5. Cresteil, T., P. Beaune & C. Celier: Cytochrome P-450 Isoenzyme content and monooxygenase activities in rat liver: effect of ontogenesis and pretreatment by phenobarbital and 3-methylcholanthrene. J. Pharmacol. Exp. Therap. 1986, 236, 269-276.
6. De Vane, C. L., J. W. Simpkins & S. A. Stout: Distribution of phenobarbital and phenytoin in pregnant rats and their fetuses. Epilepsia 1991, 32, 250-256.
7. Fishman, R. H. B. & J. Yanai: Long-lasting effects of early barbiturates on central nervous system and behavior. Neurosci. Biobehav. Rev. 1983, 7, 19-28.
8. Fujita, I., R. K. Sindhu & Y. Kikkawa: Hepatic cytochrome P450 enzyme imprinting in adult rat by neonatal benzo[a]pyrene adminissyration. Pediatr. Res. 1995, 37, 646-651.
9. Goldberg, M. D.: The expanding role of microsomal enzyme induction, and its implications for clinical chemistry. Clin. Chem. 1980, 26, 691-699.
10. Isogai, M., N. Shimada & T. Kamataki: Change in the amount of cytochromes P450 in rat hepatic microsomes produced by cyclosporin A. Xenobitica 1993, 23, 799-807.
11. Kaneko, S., T. Sato & K. Suzuki: The levels of anticonvulsants in breast milk. Brit. J. Clin. Pharmac. 1979, 7, 624-626.
12. Kikkawa, Y., I. Fujita & R. K. Sindhu: Neonatal hypoxia and cytochrome P450 imprinting in adulthood. Pediatr. Res. 1994, 35, 255-259.
13. Kobliakov, V., N. Popova & L. Rossi: Regulation of the expression of the sex-specific isoforms of cytochrome P-450 in rat liver. Eur. J. Biochem. 1991, 195, 585-591.
14. Kocarek, T. A., E. G. Schuetz & P. S. Guzelian: Differentiated induction of Cytochrome P450b/e and P450p mRNA by dose of phenobarbital in primary culture of adult rat hepatocytes. Mol. Pharmacol. 1990, 38, 440-444.
15. Kurata, N., T. Yoshida & Y. Kuroiwa: Long-term effects of phenobarbital on rat liver microsomal drug-metabolizing enzymes and heme-metabolizing enzyme. Res. Commun. Chem. Pathol. 1989, 65, 405-426.
16. Lowry, O. H., N. J., Rosebrough, A. L., Farr et al.: Protein measurement with the Folin Phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
17. Lubet, R. A., R. T. Mayer, J. W. Cameron et al.: Dealkylation of pentoxyresorufin: A rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat. Arch. Biochem. Biophys. 1985, 238, 43-48.
18. Mastroiacovo, P. R. Bertllini, D. Licata et al.: Fetal growth in the offspring of epileptic women results of an Italian multicentric chort study. Acta. neurol. scand. 1988, 78, 110-114.
19. Mizokami, K., K. Inoue, M. Sunouchi et al.: 3-Methylcholanthrene induces phenobarbital-induced cytochrome p-450 hemoprotein in fetal liver and not cytochrome p-448 hemoprotein induced in maternal liver of rats. Biochem. Biophys. Res. Commun. 1982, 107, 6-11.
20. Moriyama, M., S. Yamashita, K. Furuno et al.: Influence of lactation on plasma phenobarbital concentrations in rats. Jap. J. Pharmacol. 1997, 73, 191-196.
21. Niwa, T., H. Kaneko, Y. Naritomi et al.: Species and sex differences of liver microsomes of rat, dog and monkey. Xenobiotics. 1995, 25, 1041-1049.
22. Paolini, M., R. Mesirca, L. Pozzetti et al.: Molecular non-genetic biomarkers related to fenarimol cocarcinogenesis: organ- and sex- specific CYP induction in rat. Cancer Lett. 1996, 101, 171-178.
23. Pellock, J. M.: Standard approach to antiepileptic drug treatment in the united states. Epilepsia 1994, 35 (Suppl.4) S11-S18.
24. Reinisch, J. M., S. A. Sanders, E. L. Mortensen et al.: In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA 1995, 274, 1581-1525.
25. Waxman, D. J. & L. Azaroff: Phenobarbital induction of cytochrome P-450 gene expression. Biochem. J. 1992, 281, 557-592.
26. Waxman, D. J., A. Ko & C. Walsh: Regioselectivity and stereoselectivity of androogen hydroylations catalysed by cytochrome P-450 isozymes purified from phenobarbital-induced rat liver. J. Biol. Chem. 1983, 258, 11937-11947.